In conclusion, Danshensu and HSYA individually has significant therapeutic effects on ischemic stroke but Danshensu and HSYA in combination appeared to possessed additive or synergistic protective effects, which may relate to the better regulation on TLR4/NF-κb and Nrf2/HO-1 pathways. The gene discussed is NFE2L2; the disease is ischemic stroke.